“…Nevertheless, therapeutic potentials of AMSs have not received a substantially deep attention, we therefore try here to highlight the recent progress conducted on the metal complexes employed in mimetic cleavage studies of nucleic acids and shed a light on their potential therapeutic applications. Metal complexes possess rich structural and electronic properties as well as redox-active centers which enable them to cleave nucleic acids through hydrolysis [27] , [28] and/or by generating reactive oxygen species (ROS) (oxidative cleavage and photocleavage) [29] , [30] , [31] , [32] , [33] . A rich library of DNA/RNA–cleaving metal complexes have been prepared and submitted to pharma studies as novel therapeutic candidates for the treatment of diseases such as cancer [13] , [14] , [34] , [35] , [36] , [37] , [38] , [39] , bacterial [13] , [14] , [39] , [40] , [41] , [42] , [43] , [44] , [45] and viral infections [13] , [14] , [46] , [47] , [48] , [49] , and gene therapy [50] , [51] .…”